Valuation: BICO Group AB

Market Cap 171.14Cr 17Cr 15Cr 14Cr 13Cr 24Cr 1.64TCr 25Cr 67Cr 855.89Cr 65Cr 63Cr 2.73TCr P/E 2026 *
-7.53x
P/E 2027 * -13.5x
Enterprise Value 164.24Cr 17Cr 15Cr 14Cr 12Cr 23Cr 1.57TCr 24Cr 64Cr 821.38Cr 62Cr 61Cr 2.62TCr EV / Sales 2026 *
1.01x
EV / Sales 2027 * 0.92x
Free-Float
69.88%
Yield 2026 *
-
Yield 2027 * -
1 day+39.45%
1 week+39.45%
Current month+39.45%
1 month+20.39%
3 months+91.65%
6 months+20.65%
Current year+27.24%
1 week 0.71
Extreme 0.7068
0.71
1 month 0.51
Extreme 0.506856
0.71
Current year 0.35
Extreme 0.35
0.71
1 year 0.35
Extreme 0.35
0.75
3 years 0.35
Extreme 0.35
1.55
5 years 0.35
Extreme 0.35
13.31
10 years 0.35
Extreme 0.35
14.8
Manager TitleAgeSince
Chief Executive Officer 51 01/09/2026
Director of Finance/CFO 56 01/03/2026
Chief Operating Officer - 07/01/2026
Director TitleAgeSince
Director/Board Member 71 18/12/2019
Director/Board Member 37 01/03/2015
Director/Board Member 51 07/05/2026
Change 5-day change 1-year change 3-year change Capi.($)
+39.45%+39.45% - - 17Cr
-0.93%+4.86%+28.03%+42.34% 26TCr
-1.06%+4.20%+9.56%+8.07% 16TCr
-0.27%+0.65%-4.36%+54.96% 15TCr
+0.57%+3.88%-55.27%-12.03% 6.43TCr
+1.47%+5.90%-13.25%-13.43% 5.19TCr
-1.70%+1.63%+16.02%+23.13% 4.99TCr
-0.85%+4.81%+9.39%+49.25% 5.03TCr
-1.47%+1.42%+21.88%+53.89% 4.88TCr
-1.62%+0.73%+30.59%+70.27% 4.29TCr
Average +3.36%+3.65%+4.73%+30.72% 9.72TCr
Weighted average by Cap. -0.68%+4.13%+8.51%+32.22%

Financials

2026 *2027 *
Net sales 162.2Cr 16Cr 15Cr 13Cr 12Cr 23Cr 1.55TCr 24Cr 64Cr 811.16Cr 61Cr 60Cr 2.59TCr 168.55Cr 17Cr 15Cr 14Cr 13Cr 24Cr 1.62TCr 24Cr 66Cr 842.91Cr 64Cr 63Cr 2.69TCr
Net income -23Cr -2.29Cr -2.04Cr -1.89Cr -1.72Cr -3.24Cr -217.54Cr -3.29Cr -8.9Cr -113.52Cr -8.6Cr -8.42Cr -361.89Cr -13Cr -1.27Cr -1.13Cr -1.05Cr -95.37L -1.8Cr -120.75Cr -1.83Cr -4.94Cr -63Cr -4.77Cr -4.67Cr -200.87Cr
Net Debt -6.9Cr -69.67L -61.93L -57.4L -52.23L -98.55L -66Cr -1Cr -2.71Cr -35Cr -2.61Cr -2.56Cr -110Cr -17Cr -1.68Cr -1.49Cr -1.38Cr -1.26Cr -2.37Cr -159.08Cr -2.41Cr -6.51Cr -83Cr -6.29Cr -6.16Cr -264.64Cr
Projected Income Statement - Annual - BICO Group AB
Logo BICO Group AB
BICO Group AB, previously Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Company develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.
Employees
554
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - BICO Group AB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
24.25SEK
Average target price
29.00SEK
Spread / Average Target
+19.59%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - BICO Group AB